Hanmi Pharmaceutical: This Korean Pharma Giant's Stock Could Rebound More than 50%.
Hanmi Pharm Co Ltd (128940 KS)Â stock has fallen from recent highs after Boehringer pulled out of an oncology deal and short-sellers piled on the...
806 Views
The Chickens Are Ready to Roost
Several recent developments confirm our thesis that Inflectra's US sales in 2017 will fall far short of management's 2017 forecast. First, Pfizer's...
337 Views
More Harsh Reality from Teva
U.S. healthcare industry leaders from across the spectrum of industry segments continue to downplay the near-term adoption of biosimilars in the...
335 Views
Bioepis Details Don't Support the Valuation
We are following up on our previous post on the proposed listing of Samsung BioLogics US$9 Billion Valuation Is Rarefied Air  in response to...
430 Views
Ildong Pharmaceutical Spin-Off:Â A Special Situations Gem
Ildong Pharmaceutical Co., Ltd. (000230 KS) spin-off is a special situations gem. We expect the combined values of Ildong Pharmaceutical and...
810 Views